Legal & General Group
CNMD icon

Legal & General Group’s CONMED CNMD Stock Holding History

Legal & General Group’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.73M Sell
133,663
-13,759
-9% -$560K ﹤0.01% 1530
2025
Q4 		$5.99M Buy
147,422
+40,419
+38% +$1.76M ﹤0.01% 1463
2025
Q3 		$5.03M Buy
107,003
+2,638
+3% +$137K ﹤0.01% 1572
2025
Q2 		$5.44M Buy
104,365
+7,913
+8% +$434K ﹤0.01% 1511
2025
Q1 		$5.82M Sell
96,452
-1,753
-2% -$113K ﹤0.01% 1449
2024
Q4 		$6.72M Buy
98,205
+1,961
+2% +$137K ﹤0.01% 1409
2024
Q3 		$6.92M Buy
96,244
+758
+0.8% +$53.5K ﹤0.01% 1402
2024
Q2 		$6.62M Sell
95,486
-201
-0.2% -$14.7K ﹤0.01% 1369
2024
Q1 		$7.66M Buy
95,687
+3,381
+4% +$301K ﹤0.01% 1291
2023
Q4 		$10.1M Sell
92,306
-4,514
-5% -$467K ﹤0.01% 1135
2023
Q3 		$9.76M Sell
96,820
-1,243
-1% -$143K ﹤0.01% 1091
2023
Q2 		$13.3M Sell
98,063
-2,240
-2% -$273K ﹤0.01% 971
2023
Q1 		$10.4M Sell
100,303
-1,441
-1% -$139K ﹤0.01% 1044
2022
Q4 		$9.02M Buy
101,744
+1,501
+1% +$125K ﹤0.01% 1110
2022
Q3 		$8.04M Buy
100,243
+3,714
+4% +$350K ﹤0.01% 1137
2022
Q2 		$9.24M Buy
96,529
+2,671
+3% +$321K ﹤0.01% 1101
2022
Q1 		$13.9M Sell
93,858
-4,336
-4% -$605K ﹤0.01% 1007
2021
Q4 		$13.9M Buy
98,194
+259
+0.3% +$36.7K ﹤0.01% 1035
2021
Q3 		$12.8M Buy
97,935
+9,606
+11% +$1.26M ﹤0.01% 1049
2021
Q2 		$12.1M Sell
88,329
-20,356
-19% -$2.79M ﹤0.01% 1072
2021
Q1 		$14.2M Buy
108,685
+9,531
+10% +$1.15M 0.01% 1011
2020
Q4 		$11.1M Buy
99,154
+2,910
+3% +$276K ﹤0.01% 1059
2020
Q3 		$7.57M Buy
96,244
+1,872
+2% +$153K ﹤0.01% 1147
2020
Q2 		$6.79M Buy
94,372
+8,476
+10% +$590K ﹤0.01% 1170
2020
Q1 		$4.99M Buy
85,896
+1,768
+2% +$163K ﹤0.01% 1159
2019
Q4 		$9.41M Buy
84,128
+8,641
+11% +$921K ﹤0.01% 1048
2019
Q3 		$7.26M Buy
75,487
+6,314
+9% +$593K ﹤0.01% 1108
2019
Q2 		$5.92M Buy
69,173
+456
+0.7% +$37.5K ﹤0.01% 1203
2019
Q1 		$5.72M Buy
68,717
+5,883
+9% +$427K ﹤0.01% 1106
2018
Q4 		$4.01M Buy
62,834
+1,504
+2% +$103K ﹤0.01% 1193
2018
Q3 		$4.86M Buy
61,330
+5,837
+11% +$452K ﹤0.01% 1197
2018
Q2 		$4.06M Buy
55,493
+2,599
+5% +$177K ﹤0.01% 1254
2018
Q1 		$3.35M Buy
52,894
+889
+2% +$53.1K ﹤0.01% 1327
2017
Q4 		$2.65M Buy
52,005
+161
+0.3% +$8.38K ﹤0.01% 1471
2017
Q3 		$2.72M Buy
51,844
+2,155
+4% +$108K ﹤0.01% 1406
2017
Q2 		$2.53M Buy
49,689
+4,308
+9% +$213K ﹤0.01% 1394
2017
Q1 		$2.01M Buy
45,381
+322
+0.7% +$13.9K ﹤0.01% 1477
2016
Q4 		$1.99M Buy
45,059
+19,980
+80% +$849K ﹤0.01% 1392
2016
Q3 		$1M Buy
25,079
+18,221
+266% +$774K ﹤0.01% 1397
2016
Q2 		$320K Hold
6,858
– – ﹤0.01% 1578
2016
Q1 		$284K Buy
6,858
+489
+8% +$19.2K ﹤0.01% 1600
2015
Q4 		$281K Buy
6,369
+936
+17% +$40.6K ﹤0.01% 1597
2015
Q3 		$258K Hold
5,433
– – ﹤0.01% 1581
2015
Q2 		$317K Buy
5,433
+473
+10% +$25.5K ﹤0.01% 1518
2015
Q1 		$251K Buy
4,960
+1,080
+28% +$52.9K ﹤0.01% 1581
2014
Q4 		$175K Sell
3,880
-124
-3% -$5.2K ﹤0.01% 1640
2014
Q3 		$149K Buy
+4,004
New +$159K ﹤0.01% 1649

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Legal & General Group's CNMD Position: Q1 2026 in Review

Legal & General Group reduced its CONMED (CNMD) stake by 9.3% in Q1 2026, selling an estimated $560K and leaving 133,663 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Legal & General Group first reported a position in CNMD in Q3 2014 and has held it in 47 quarters since. The position peaked at $14.2M in Q1 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Legal & General Group held 133,663 shares of CONMED worth $4.73M as of Q1 2026.
  • Legal & General Group sold 13,759 CONMED shares in Q1 2026, an estimated $560K.
  • CONMED made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1530 holding.
  • Legal & General Group first reported a position in CONMED in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's CONMED position peaked at $14.2M in Q1 2021.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.